Inhibition of epstein-barr virus reactivation in nasopharyngeal carcinoma cells by dietary sulforaphane
Molecular Carcinogenesis, 05/30/2012
Wu CC et al. – The results suggest that sulforaphane (SFN) has the capability to inhibit Epstein–Barr virus (EBV) lytic cycle and the potential to be taken as a dietary compound for prevention of EBV reactivation.



